This document describes 9 methods for producing niosomes, which are non-ionic surfactant-based vesicles. The methods include ether injection, hand shaking, bubble method, reverse phase evaporation, sonication, multiple membrane extrusion, transmembrane pH gradient loading, microfluidization, and formation from proniosomes. Each method utilizes different processes like solvent evaporation, agitation, extrusion, or pH adjustments to encapsulate drugs in vesicles formed from surfactants and cholesterol.
NIOSOMES , GENERAL CHARACTERISTICS OF NIOSOME , TYPES OF NIOSOMES , OTHERS TYPES OF NIOSOMES , NIOSOMES VS LIPOSOMES , COMPONENTS OF NIOSOMES , Non-ionic surfactant , Cholesterol , Charge inducing molecule , METHOD OF PREPARATION , preparation of small unilamellar vesicles , Sonication , Micro fluidization , preparation of large unilamellar vesicles , Reverse Phase Evaporation , Ether Injection , preparation of Multilamellar vesicles , Hand shaking method , Trans membrane pH gradient drug uptake process (remote loading) , Miscellaneous method :Multiple membrane extrusion method , The “Bubble” Method , Formation of Niosomes From Proniosomes , SEPARATION OF UNENTRAPPED DRUGS , Gel Filtration , Dialysis , Centrifugation , FACTORS AFFECTING THE PHYSICOCHEMICAL PROPERTIES OF NIOSOMES , Membrane Additives , Temperature of Hydration , PROPERTIES OF DRUGS , AMOUNT AND TYPE OF SURFACTANT
Structure of Surfactants , Resistance to Osmotic Stress , Characterization of niosomes ,Therapeutic applications of Niosomes , For Controlled Release of Drugs , To Improve the Stability and Physical Properties of the Drugs , For Targeting and Retention of Drug in Blood Circulation , Proniosomes , Aspasomes , Vesicles in Water and Oil System (v/w/o) ,Bola - niosomes , Discomes , Deformable niosomes or elastic niosomes , According to the nature of lamellarity ,Small Unilamellar vesicles (SUV) 25 – 500 nm in size.,Large Unilamellar vesicles (LUV) 0.1 – 1μm in size , Multilamellar vesicles (MLV) 1-5 μm in size , According to the size:Small Niosomes (100 nm – 200 nm) , Large Niosomes (800 nm – 900 nm),Big Niosomes (2 μm – 4 μm)
NIOSOMES , GENERAL CHARACTERISTICS OF NIOSOME , TYPES OF NIOSOMES , OTHERS TYPES OF NIOSOMES , NIOSOMES VS LIPOSOMES , COMPONENTS OF NIOSOMES , Non-ionic surfactant , Cholesterol , Charge inducing molecule , METHOD OF PREPARATION , preparation of small unilamellar vesicles , Sonication , Micro fluidization , preparation of large unilamellar vesicles , Reverse Phase Evaporation , Ether Injection , preparation of Multilamellar vesicles , Hand shaking method , Trans membrane pH gradient drug uptake process (remote loading) , Miscellaneous method :Multiple membrane extrusion method , The “Bubble” Method , Formation of Niosomes From Proniosomes , SEPARATION OF UNENTRAPPED DRUGS , Gel Filtration , Dialysis , Centrifugation , FACTORS AFFECTING THE PHYSICOCHEMICAL PROPERTIES OF NIOSOMES , Membrane Additives , Temperature of Hydration , PROPERTIES OF DRUGS , AMOUNT AND TYPE OF SURFACTANT
Structure of Surfactants , Resistance to Osmotic Stress , Characterization of niosomes ,Therapeutic applications of Niosomes , For Controlled Release of Drugs , To Improve the Stability and Physical Properties of the Drugs , For Targeting and Retention of Drug in Blood Circulation , Proniosomes , Aspasomes , Vesicles in Water and Oil System (v/w/o) ,Bola - niosomes , Discomes , Deformable niosomes or elastic niosomes , According to the nature of lamellarity ,Small Unilamellar vesicles (SUV) 25 – 500 nm in size.,Large Unilamellar vesicles (LUV) 0.1 – 1μm in size , Multilamellar vesicles (MLV) 1-5 μm in size , According to the size:Small Niosomes (100 nm – 200 nm) , Large Niosomes (800 nm – 900 nm),Big Niosomes (2 μm – 4 μm)
Niosomes :it is A Novel Drug Delivery System (NDDS) advantages and dissadvatages ,structures of niosomes,methods of preparation along with applications of niosomes
Introduction
Structure
Niosomes Vs. Liposome
Advantages & Disadvantages
Properties of Niosomes
Method of Manufacturing
Evaluation of Niosomes
Applications
Marketed products
Niosomes are vesicles composed mainly of hydrated non-ionic surfactant with or without cholesterol used for targetted drug delivery. Niosomes are better than liposomes as they are cost effective, stable, and can be stored for a long period of time.
Detail description about Niosomes, aquasomes, phytosomes and their preparation and Apploication tion for M. Pharm. Pharmaceutics students as per PCI syllabus
Niosomes :it is A Novel Drug Delivery System (NDDS) advantages and dissadvatages ,structures of niosomes,methods of preparation along with applications of niosomes
Introduction
Structure
Niosomes Vs. Liposome
Advantages & Disadvantages
Properties of Niosomes
Method of Manufacturing
Evaluation of Niosomes
Applications
Marketed products
Niosomes are vesicles composed mainly of hydrated non-ionic surfactant with or without cholesterol used for targetted drug delivery. Niosomes are better than liposomes as they are cost effective, stable, and can be stored for a long period of time.
Detail description about Niosomes, aquasomes, phytosomes and their preparation and Apploication tion for M. Pharm. Pharmaceutics students as per PCI syllabus
Nanoliposomal technology and food fortification aids each other. the bio availability of many compounds in food is low due due to their poor solubility or size or intolerance to gastric environment. nanoliposomes can be the answer to this.
Pharmacopoeia is an official publication describing drugs, chemicals, and medicinal preparations as well as containing directions of compound identification. The word ‘Pharmacopoeia’ is widely used and common spelling but ‘Pharmacopeia’ used only in USP.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
Niosomes method of preparation
1. By Tushar Chavan
M Pharmacy 2018-2019
K.Y.D.S.C.T.College of Pharmacy, Sakegaon
NMU, Jalgaon [MH]
Email: tusharchavantsc@gmail.com
Updated April 30, 2019
1 Ether injection method
• This method is based on slow injection of surfactant: cholesterol solution in
ether through 14 gauge needle into a preheated aqueous phase maintained at
600C
• Vaporization of ether resulting into a formation of ether gradient at ether-
water interface which leads to formation of single layered vesicles
• Depending upon the conditions used, the diameter of the vesicle range from
50 to 1000 nm
2. Hand shaking method(Thin film hydration technique)
• Surfactant and cholesterol are dissolved in a volatile organic solvent (diethyl
ether, chloroform or methanol) in a round bottom flask
• The organic solvent is removed under vaccum at room temperature using
rotary evaporator leaving a thin layer of solid mixture deposited on the wall of
the flask
• The dried surfactant film can be rehydrated with aqueous phase at
temperature slightly above the phase transition temperature of the surfactant
used, with gentle agitation
• This process forms large multilamellar niosomes
3. The “Bubble” Method
•It is novel technique for the one step preparation of liposomes andniosomes
without the use of organic solvents
•The bubbling unit consists of round-bottom flask with three neckspositioned
in water bath to control the temperature
2. •Water-cooled reflux and thermometer is positioned in the first andsecond
neck and nitrogen supply through the third neck
• Cholesterol and surfactant are dispersed together in this buffer (pH 7.4)at
70°C, the dispersion mixed for 15 seconds with high shearhomogenizer and
immediately afterwards “bubbled at 70°C usingnitrogen gas.
4. Reverse Phase Evaporation Technique (REV)
•Cholesterol and surfactant (1:1) are dissolved in a mixture of etherand
chloroform
•An aqueous phase containing drug is added to this and the resultingtwo
phases are sonicated at 4-5°C. The clear gel formed is furthersonicated after
the addition of a small amount of phosphate bufferedsaline (PBS)
•The organic phase is removed at 40°C under low pressure. Theresulting
viscous niosome suspension is diluted with PBS and heatedon a water bath at
60°C for 10 min to yield niosomes
5. Sonication
•In this method, an aliquot of drug solution in buffer is added to
thesurfactant/cholesterol mixture in a 10-ml glass vial.
•The mixture is probe sonicated at 60°C for 3 minutes using a sonicator.
•The resultant vesicles are of small unilamellar type niosomes
.6. Multiple membrane extrusion method
• In this method, a mixture of surfactant, cholesterol and diacetyl phosphate is
preparedand then solvent is evaporated using rotary vacuum evaporator to
leave a thin film.
Thefilm is then hydrated with aqueous drug solution and the suspension thus
obtained isextruded through the polycarbonate membrane (mean pore size 0.1
mm) and thenplaced in series up to eight passages to obtain uniform size
niosomes.
•Good method of controlling niosome size.
7. Trans membrane pH gradient (inside acidic) Drug Uptake Process (remote
Loading)
•Surfactant and cholesterol are dissolved in chloroform
3. • The solvent is then evaporated under reduced pressure to get a thin film on
thewall of the round bottom flask
•The film is hydrated with 300 mM citric acid (pH 4.0) by vortex mixing.
•The multilamellar vesicles are frozen and thawed 3 times and later sonicated.
To this niosomal suspension, aqueous solution containing 10 mg/ml of drug is
added and vortexed
• The pH of the sample is then raised to 7.0-7.2 with 1M disodium phosphate•
This mixture is later heated at 60°C for 10 minutes to give niosomes
8. Microfluidization Method
In this method two fluidized streams (one containing drug and the other
surfactant) interact at ultra-high velocity, in precisely defined micro channels
within the interaction chamber in such a way that the energy supplied to the
system remains in the area of niosomes formations.
This is called submerged jet principle. It results in better uniformity, smaller
size and reproducibility in the formulation of niosomes
9. Formation of Niosomes from Proniosomes
•Another method of producing niosomes is to coat a water-solublecarrier such
as sorbitol with surfactant
• The result of the coating process is a dry formulation. In which eachwater-
soluble particle is covered with a thin film of dry surfactant. Thispreparation is
termed “Proniosomes”
•The niosomes are formed by the addition of aqueous phase at T > T mand
brief agitation T = Temperature. Tm = mean phase transition temperature